News
Guidelines updated for treating community-acquired pneumonia
News
Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study
MADRID – “One day after taking the first pill, you can see really nice reductions in itch at both doses, compared with placebo.”
Article
Child Neurology Society 2019
Coming soon!
News
SPARTAN: Apalutamide delays second progression in nonmetastatic CRPC
BARCELONA – The androgen receptor inhibitor also appeared to show an overall survival benefit, but it did not reach significance in an interim...
News
FDA gives nod to earlier use of Nplate in adults with ITP
The drug is now indicated for newly diagnosed and persistent adult patients with immune thrombocytopenia and an insufficient response to other...
News
Balloon pulmonary angioplasty beats riociguat in randomized CTEPH trial
MADRID – Balloon pulmonary angioplasty appears to be a better first-line than riociguat for nonoperable chronic thromboembolic pulmonary...
News
Obesity ups type 2 diabetes risk far more than lifestyle, genetics
BARCELONA –
News
Closed-loop delivery system increases time in target glucose range
Patients with type 1 diabetes spent an additional 2.6 hr/day in the target range, compared with those using an insulin pump.
News
Which patients are most likely to have a positive RNS test for myasthenia gravis?
AUSTIN, TEX. – The diagnostic yield of the test may be highest in patients with MGFA Class III or higher who are...
News
Study examines utility of repeat outpatient electrodiagnostic testing
AUSTIN, TEX. – Repeat testing for the same indication may not change symptom or disease management in about one-third of cases, a preliminary...